The Oxford Antibiotic Group sees both therapy and prophylaxis as important factors in preventive healthcare and in the management of diseases
Out of this motivation, a substantial pipeline with outstanding potential has been developed which contains pharmaceuticals for therapy and med-tech products for prevention.